The increasing number of interventions for percutaneous aortic valve replacement (AVR) justify a renewed evaluation of one-year survival rates after open AVR with and without coronary artery bypass in octogenarians. Risk factors influencing mortality are compared, and the patients' quality-of-life (QoL) after one year is assessed. One hundred and fifty-four patients (102 females, 52 males) aged on average 82.9"2.5 years, who had undergone open bioprosthetic AVR with (ns80) and without (ns74) coronary artery bypass grafting (CABG) between January 2005 and December 2007 were reviewed retrospectively. Risk factors for mortality were analyzed. The patient's QoL after one year was evaluated by administering the Seattle Angina Questionnaire on the telephone. The mean in-hospital mortality rate was 7.8%. The 12-month survival rate was 81.8%. Preoperative risk factors revealed no difference between survivors and non-survivors: renal insufficiency, chronic obstructive pulmonary disease (COPD), diabetes, cerebrovascular disease (CVD), peripheral vascular disease, logistic EuroSCORE and concomitant CABG. Assessment of QoL revealed a substantial improvement of physical fitness in all 126 patients. Surgery in the aortic valve without CABG is associated with a good outcome. The improvement in QoL after one year supports the decision to operate on patients older than 80 years of age.
Introduction
Severe aortic valve stenosis and coronary heart disease in elderly patients are an increasing challenge for cardiac surgeons as well as cardiologists. The indications for open aortic valve replacement (AVR) with and without coronary artery bypass grafting (CABG) in octogenarians are an improvement in quality-of-life (QoL) and survival. Risk factors for surgical mortality and morbidity have been defined in several studies w1, 2x. However, data concerning postoperative QoL and physical fitness are scarce w3x. We reviewed octogenarians who had undergone cardiac surgery in order to assess the treatment and identify improvement in the patient's QoL after one year.
Patients and methods
From January 2005 to December 2007, we reviewed 154 patients aged on average 82.9"2.5 years. The likelihood of mortality due to preoperative comorbidities was rated using the European System for Cardiac Operative Risk Evaluation (EuroSCORE) w4x. Risk factors were compared between 30-day survivors and non-survivors. Data obtained at the one-year follow-up were evaluated by the x -test 2 *Corresponding author. Tel.: q43 664y853 0 271; fax: q43 1 80110 2821. E-mail address: s.folkmann@gmx.at, sandra.folkmann@wienkav.at (S. Folkmann). and the Mann-Whitney test. Physical fitness and QoL were assessed after one year by administering the Seattle Angina Questionnaire on the telephone. The questionnaire consists of 19 items measuring five dimensions of coronary artery disease: physical limitation, stability of angina, frequency of angina, satisfaction with the treatment, and perception of the disease w5x. Structured clinical records were retrospectively collected in a database. Renal insufficiency was determined on the basis of blood creatinine levels. Chronic obstructive pulmonary disease (COPD) was graded according to Gold grades I-IV; grade IV signified a severe restriction of pulmonary function. Further risk factors, such as diabetes, cerebrovascular disease (CVD) and peripheral vascular disease (PVD) were registered. Postoperative complications, such as stroke were defined as a new focal neurological deficit or coma. The duration of the postoperative stay at the intensive care unit (ICU) and possible readmission to the ICU were compared between patients with isolated AVR and those with additional CABG. KaplanMeier survival curves included 30-day and one-year mortality.
Results
One hundred and fifty-four patients (102 females, 52 males) older than 80 years of age, who had undergone isolated AVR and AVR with additional CABG were investi- Table 1 . Patients with isolated aortic valve stenosis (ns74) were all given aortic bioprostheses. Concomitant CABG was performed in 80 patients. The overall 30-day mortality rate was 7.8%; 30-day mortality after isolated AVR was 6.8% (five patients) and that after additional CABG was 8.8% (seven patients). The most common causes of death among the 12 patients who died were complications of the lung, such as pneumonia or edema in 41.6% (ns5) and cardiac insufficiency in 33.3% (ns4). The causes of death in the 30-day postoperative period are shown in Table 2 . Among patients who received AVR alone, cerebral complications, such as transient ischemic attack (TIA) occurred in one patient (1.3%) and stroke occurred in four patients (5.4%).
Of those who received concomitant CABG, two patients (2.5%) had a TIA and three (3.8%) had a stroke. One patient (1.3%) died after a TIA within 30 days postsurgery while two (2.7%) patients died of severe stroke within one year postsurgery. The median duration of the stay at the ICU was 3.9 days after isolated AVR and six days after concomitant CABG. Four patients (5.4%) had to be readmitted to the ICU after AVR and one patient (1.3%) after AVR with CABG.
The Kaplan-Meier estimate of one-year survival for octogenarians was 81.8% (Fig. 1) . The one-year mortality rate for isolated AVR was 16.2% and that for CABG was 20%. Mortality predicted by the logistic EuroSCORE after AVR was median 12.3% for one-year survivors vs. 13% for nonsurvivors (Ps0.64). In the presence of concomitant CABG, the predicted mortality by the logistic EuroSCORE was median 50.8% for survivors vs. 57.1% for non-survivors (Ps0.69). The logistic EuroSCORE did not differ significantly between groups. Reasons for one-year mortality were cardiac failure (ns9; 32.3%), respiratory failure (ns7; 25%), neurological damage (ns1; 3.5%), multiple organ failure (ns3; 10.8%), sepsis (ns1; 3.5%), bowel ischemia (ns1; 3.5%), and carcinoma (ns1; 3.5%), while the causes of death were not known in five patients. Details are listed in Table 2 . Compared to 30-day mortality, cardiac causes of death were more common (32.3%) than pulmonary causes in the early postoperative phase. At the one-year follow-up investigation it was found that preoperative risk factors did not differ significantly between survivors and non-survivors (Table 3) . Both groups had a similar frequency of risk factors except PVD, which was present in 7.9% of one-year survivors and 21.4% of one-year non-survivors; however, the difference did not achieve statistical significance.
On the assessment of QoL after one year, performed in 126 patients, an obvious improvement in QoL was registered in 96% while 33% had a mild reduction in their physical fitness. Forty-two percent experienced a minimal restriction in their activities of daily living. Besides, 74% of patients had less severe symptoms, such as angina or dyspnea, 18% had the same intensity of angina, and only 8% experienced more severe symptoms after surgery. Five percent of patients experienced angina or dyspnea daily while 52% had no complaints. The remaining 43% of patients experienced angina about two or three times a week. Angina did not impair QoL in 57% of patients. A further 41% reported mild impairment of their QoL and 2% reported severe restriction of their QoL secondary to heart disease. We inquired about personal circumstances, how patients coped with activities of daily living, and persons from whom they received support: 66% were living alone and 20% were living with their partner. Approximately 20% of patients were supported by their families, 25% received support from organizations, such as home nursing, and 7% availed themselves of a daily food delivery service. Only 10% were living in homes for senior citizens.
DiscussionyConclusion
The study showed an acceptable one-year survival rate after cardiac surgery in octogenarians w6, 7x, and adequately justifies the decision to operate on the aortic valve and perform concomitant CABG in elderly patients. The predicted mortality was higher than the actual mortality. The logistic EuroSCORE and other risk factors showed no significant difference between survivors and non-survivors. None of the preoperative risk factors permitted assessment of the actual mortality rate. PVD was obviously more common among non-survivors than among survivors, this risk factor may have achieved statistical significance if more patients had been included in the study. The overall 30-day mortality rate was as low as 7.8%, comparable to de Vincentiis et al. w8x the in-hospital mortality rate was 8.5% and to Vicchio et al. w9x the hospital mortality was 8.8%. Thirty-day mortality rates after percutaneous AVR have been reported to range between 12% w10x and 25% w11x, and intraprocedural mortality between 2% w10x and 8% w11x. Similar rates of stroke have been reported with either technique: about 4% w10x after percutaneous AVR vs. 5.4% after open AVR. The main complications of the percutaneous technique are left ventricular dysfunction with non-revascularized coronary artery disease and the potential for global ischemia during the procedure. Injury due to the vascular access, atheroembolism and paravalvular leak may also occur w10x. The increasing numbers of patients with aortic valve stenosis signifies that conventional valve replacement is still required w12x. AVR surgery remains the treatment of choice for symptomatic aortic stenosis w10x, but will be unable to entirely replace conventional AVR. According to Thourani et al. w7x , an increasing body of evidence suggests that traditional surgical AVR can be performed safely in octogenarians and is associated with acceptable morbidity and short-term mortality rates. Analogous to our data, Thourani et al. report an in-hospital mortality rate of 5.7%. Sundt et al. w13x from the Mayo Clinic registered a one-year survival rate of 80% in octogenarians undergoing AVR with or without concomitant CABG. Vicchio et al. w9x report a survival rate of 86.4% one year after tissue AVR. This is comparable to our one-year survival rate of 81.8%. In conclusion, our study showed that AVR performed in the elderly, with or without CABG, is associated with favorable results in terms of early and mid-term mortality. One year after cardiac surgery, octogenarians reported better QoL. Specifically, chest pain and physical fitness for activities of daily living were improved w14, 15x. Markou et al. w3x emphasizes the improvement in QoL after surgery. CABG is beneficial in terms of providing relief from angina and improves QoL. All of the one-year survivors did not regret having undergone cardiac surgery. Particularly, the marked improvement in QoL after one year strongly favors the use of surgery for this indication even in the elderly.
In conclusion, our clinical as well as QoL data one year after operation supports the decision to operate on octogenarians. These good results of conventional surgery have to be taken into account when discussing the indication for interventional aortic valve implantation.
